search
Back to results

Dance and Movement Therapy in Patients With Schizophrenia (DMTinSchizo)

Primary Purpose

Schizophrenia, Negative Symptoms in Schizophrenia, Disabilities Mental

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Dance and Movement Therapy (DMT)
Sponsored by
Amasya University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Schizophrenia focused on measuring Dance and movement therapy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • have been diagnosed with schizophrenia for at least two years
  • not have been hospitalized in the past 3 months

Exclusion Criteria:

  • have a therapy/psychoeducation program that they attend regularly
  • have a known physical or neurological disease
  • having just started the Community Mental Health Center

Sites / Locations

  • Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Ve Araştirma Hastanesi

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental group

Control group

Arm Description

Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.

Outcomes

Primary Outcome Measures

The Scale for the Assessment of Negative Symptoms (SANS)
Scale; It consists of five parts, including flattening or blunting in affect, alogy, decreased energy and desire, lack of pleasure and social withdrawal, attention, and a total of 24 items. Scale items 0=none; 1=doubtful; 2=light; 3=medium; 4=pronounced; It is scored as 5=severe. The negative symptoms rating scale is a type of scale that the interviewer evaluates. The filling of the scale is based on the interview with the patient, the observations during the interview and the information received from the people around the patient. Cronbach's alpha for the whole scale is 0.94. Values that can be taken from the Scale for the Assessment of Negative Symptoms (SANS); minimum=0, maximum=120 points. It shows that as the score increases, the severity of negative symptoms increases.
Disability Evaluation Schedule (WHO-DAS-II)
Disability Assessment Chart is a 36-item scale. This tool tries to determine how much difficulty an individual with schizophrenia has while performing certain activities and consists of 6 areas that include activities that are considered important in many cultures. These are grouped under the headings of understanding and communicating, moving and moving from place to place, self-care, human relations, life activities, participation in social life. In questions about all these areas, it is asked how much difficulty the person has had during that activity in the last month, and the answers received as not at all, mild, moderate, very much, excessively/not at all are scored between 1-5. It is applied by the interviewer in approximately 20 minutes. Cronbach's alpha for the whole scale is 0.92. Values that can be taken from the Disability Evaluation Schedule (WHO-DAS-II); minimum=0, maximum=100 points. It shows that as the score increases, the severity of disability increases.

Secondary Outcome Measures

Full Information

First Posted
August 10, 2022
Last Updated
May 21, 2023
Sponsor
Amasya University
search

1. Study Identification

Unique Protocol Identification Number
NCT05500651
Brief Title
Dance and Movement Therapy in Patients With Schizophrenia
Acronym
DMTinSchizo
Official Title
The Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
September 1, 2022 (Actual)
Primary Completion Date
December 6, 2022 (Actual)
Study Completion Date
February 15, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Amasya University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Introduction: Schizophrenia is a mental disorder that starts at a young age and progresses with positive (hallucination, delusion) and negative (decreased emotional participation, reluctance) symptoms. While drug therapy in schizophrenia targets positive symptoms; psychotherapies are needed in the treatment of negative symptoms. It is seen that especially art therapies such as occupational and music support recovery and rehabilitation. In addition, it is stated that dance and movement therapy is effective in ensuring social participation of patients. There are a limited number of studies demonstrating the effect of dance and movement therapy on schizophrenia patients. Aim: This project was planned to examine the effects of dance and movement therapy techniques to be applied to patients with schizophrenia on patients' negative symptoms and disability. Method: In this project, which was planned in a repetitive measure design with a pretest-posttest control group, dance and movement therapy techniques, consisting of 12 sessions in total, will be applied to schizophrenic patients in a Community Mental Health Center once a week. Negative symptoms and disability levels will be determined before, after and a month after the application. The findings obtained as a result of these three follow-ups will be evaluated. Project Outputs: Reduction of negative symptoms and disability will enable schizophrenic patients to become individuals who can express themselves better in their family and society and have an increased quality of life. It is thought that these gains will increase patients' compliance with treatment, prevent recurrent symptoms and reduce hospitalizations. The results will also constitute a scientific source for the studies to be carried out in the field.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Negative Symptoms in Schizophrenia, Disabilities Mental, Dance Therapy
Keywords
Dance and movement therapy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A repetitive measure design with a pretest-posttest control group
Masking
Participant
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.
Arm Title
Control group
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
Dance and Movement Therapy (DMT)
Intervention Description
Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.
Primary Outcome Measure Information:
Title
The Scale for the Assessment of Negative Symptoms (SANS)
Description
Scale; It consists of five parts, including flattening or blunting in affect, alogy, decreased energy and desire, lack of pleasure and social withdrawal, attention, and a total of 24 items. Scale items 0=none; 1=doubtful; 2=light; 3=medium; 4=pronounced; It is scored as 5=severe. The negative symptoms rating scale is a type of scale that the interviewer evaluates. The filling of the scale is based on the interview with the patient, the observations during the interview and the information received from the people around the patient. Cronbach's alpha for the whole scale is 0.94. Values that can be taken from the Scale for the Assessment of Negative Symptoms (SANS); minimum=0, maximum=120 points. It shows that as the score increases, the severity of negative symptoms increases.
Time Frame
6 months
Title
Disability Evaluation Schedule (WHO-DAS-II)
Description
Disability Assessment Chart is a 36-item scale. This tool tries to determine how much difficulty an individual with schizophrenia has while performing certain activities and consists of 6 areas that include activities that are considered important in many cultures. These are grouped under the headings of understanding and communicating, moving and moving from place to place, self-care, human relations, life activities, participation in social life. In questions about all these areas, it is asked how much difficulty the person has had during that activity in the last month, and the answers received as not at all, mild, moderate, very much, excessively/not at all are scored between 1-5. It is applied by the interviewer in approximately 20 minutes. Cronbach's alpha for the whole scale is 0.92. Values that can be taken from the Disability Evaluation Schedule (WHO-DAS-II); minimum=0, maximum=100 points. It shows that as the score increases, the severity of disability increases.
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Personal Information Form
Description
The questionnaire form prepared by the project team consists of 10 questions in total, including the socio-demographic characteristics (age, gender, marital status, education level, employment status, income level, cohabitants) of the patients and their disease-related characteristics (age of onset of disease, duration of disease (years), number of hospitalizations).
Time Frame
2 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: have been diagnosed with schizophrenia for at least two years not have been hospitalized in the past 3 months Exclusion Criteria: have a therapy/psychoeducation program that they attend regularly have a known physical or neurological disease having just started the Community Mental Health Center
Facility Information:
Facility Name
Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Ve Araştirma Hastanesi
City
Amasya
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Dance and Movement Therapy in Patients With Schizophrenia

We'll reach out to this number within 24 hrs